NIH Guide: Weekly Index for July 9, 2021

Funding Opportunities

• PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
  (PA-21-259)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply
• PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
  (PA-21-260)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply
• PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
  (PA-21-261)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply
• PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
  (PA-21-262)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply
• Large Research Projects for Prevention of Healthcare-Associated Infections (R01)
  (PA-21-265)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): October 5, 2021
• NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials)
  (PAR-21-239)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
  (PAR-21-246)
  John E. Fogarty International Center
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is September 25, 2021. All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)
  (PAR-21-248)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)
  (PAR-21-253)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional)
  (PAR-21-263)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)
  (PAR-21-264)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans)
  (PAR-21-280)
  NIH Basic Behavioral and Social Science Opportunity Network
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Multiple dates, see announcement.
• Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed)
  (PAR-21-281)
  NIH Basic Behavioral and Social Science Opportunity Network
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Multiple dates, see announcement.
• Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed)
  (RFA-AG-22-022)
  National Institute on Aging
  Application Receipt Date(s): October 28, 2021
• Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
  (RFA-AG-22-027)
  National Institute on Aging
  Application Receipt Date(s): November 02, 2021
• Innate Immune Memory Impacting HIV Acquisition and/or Control (R21 Clinical Trial Not Allowed)
  (RFA-AI-21-041)
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  Application Receipt Date(s): Not Applicable
• Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed)
  (RFA-AI-21-050)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): October 22, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional)
  (RFA-CA-21-021)
  National Cancer Institute
  Application Receipt Date(s): October 06, 2021
• Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed)
  (RFA-CA-21-022)
  National Cancer Institute
  Application Receipt Date(s): October 06, 2021
• Growing Great Ideas: Research Education Course in Product Development and Entrepreneurship for Life Science Researchers (UE5 Clinical Trial Not Allowed)
  (RFA-DA-22-020)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 18, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
• HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed)
  (RFA-DA-22-031)
  National Institute on Drug Abuse
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): October 19, 2021
• HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed)
  (RFA-DA-22-032)
  National Institute on Drug Abuse
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): October 19, 2021
• Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional)
  (RFA-DA-23-001)
  National Institute on Drug Abuse
  Application Receipt Date(s): Not Applicable
• Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions Knowledgebase Management Center (U24 Clinical Trial Not Allowed)
  (RFA-DK-21-014)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed)
  (RFA-HG-21-001)
  National Human Genome Research Institute
  National Cancer Institute
  Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed)
  (RFA-HG-21-002)
  National Human Genome Research Institute
  Application Receipt Date(s): October 1, 2021; June 15, 2022; June 15, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.